Considered as one of the best doctors by the Castle Connolly, Dr. Gil Melmed is a renowned Gastroenterologist highly specialized in the approach of Inflammatory Bowel Diseases. In this way, he has developed most of his career in health entities of international reference among which stands out the Cedars-Sinai Medical Center in California.  

Among his main achievements, he has used innovative Computer Aided Detection devices in multiple colonoscopies. Therefore, he has demonstrated that these technological tools pertaining to Artificial Intelligence can significantly increase the identification of Adenomas or Polyps and improve the prevention of Colorectal Cancer. Along the same lines, he has promoted the IBD QORUS Quality Improvement Program, focused on the implementation of excellent practices and quality standards in the treatment of patients with Inflammatory Bowel Disease. Thanks to this, it has managed to optimize both medical results and user experience.

He also balances this work with his role as a clinical researcher. In fact, he has developed numerous studies focused on subjects such as new treatments for the management of chronic inflammation of the intestine, cutting-edge procedures aimed at perfecting postoperative care or techniques that ensure that individuals' responses to vaccines are effective and safe. Consequently, he has spearheaded a number of sophisticated strategies that have enabled individuals to experience adequate recovery following their surgical procedures.  

Committed to the advances in this health field, he participates as a speaker in different international scientific congresses. There he has shared his experience using advanced diagnostic tests, such as Balloon Enteroscopy. He has also increased the knowledge of health professionals on the most optimal methods to treat Crohn's Disease and Ulcerative Colitis.

• Director of Clinical Trials at the Center for Inflammatory Bowel Diseases at Cedars-Sinai Medical Center in Los Angeles, California
• President of the American Gastroenterological Association's Committee on Inflammatory Bowel Diseases 
• Clinical Investigator at Cedars-Sinai Medical Center 
• Editor of the "American Journal of Gastroenterology" 
• Residency at Cedars-Sinai Medical Center 
• M.D. from Albert Einstein College of Medicine 
• Master of Science in Clinical Research, University of California, California 
• B.S. in Medical Sciences, University of Pennsylvania 
• Fellowship in Gastroenterology from University of California 
• Board Certified by the American Board of Internal Medicine  
• Member of: 
  
  • Crohn's and Colitis Foundation National Scientific Advisory Board 
  • Co-Chair of the IBD QORU Quality Improvement Program